Scl-70 (100) antibodies

Indication

Scl-70 is included in analysis ENA screen. See therefore “ENA screen” for indication, method, answer and reference range.

Interpretation

Positive in about 15% of patients with scleroderma, especially with the systemic progressive form (diffuse progressive systemic sclerosis). Patients with Raynaud’s syndrome and positive anti Scl-70(100) often later develop typical diffuse progressive systemic scleroderma.

Read more about sampling

Own immunologist